Characterization of Apo‐Form Selective Inhibition of Indoleamine 2,3‐Dioxygenase**-Reference-Cited by-同舟云学术

Characterization of Apo‐Form Selective Inhibition of Indoleamine 2,3‐Dioxygenase**

Published:2020-11-16 Issue:3 Volume:22 Page:516-522
ISSN:1439-4227
Container-title:ChemBioChem
language:en
Short-container-title:ChemBioChem

Author:

Ortiz‐Meoz Rodrigo F.¹^ORCID,Wang Liping¹,Matico Rosalie¹,Rutkowska‐Klute Anna²,De la Rosa Martha³,Bedard Sabrina¹,Midgett Robert¹,Strohmer Katrin²,Thomson Douglas²,Zhang Cunyu¹,Mebrahtu Makda¹,Guss Jeffrey¹,Totoritis Rachel¹,Consler Thomas¹,Campobasso Nino¹,Taylor David¹,Lewis Tia¹,Weaver Kurt¹,Muelbaier Marcel²,Seal John¹,Dunham Richard³,Kazmierski Wieslaw³^ORCID,Favre David³,Bergamini Giovanna²,Shewchuk Lisa¹,Rendina Alan¹,Zhang Guofeng¹^ORCID

Affiliation:

1. Drug Design and Selection, GlaxoSmithKline 1250 S. Collegeville Road Collegeville, PA 19426 USA

2. Cellzome GmbH, GlaxoSmithKline Meyerhofstrasse 1 69117 Heidelberg Germany

3. Infectious Diseases TAU GlaxoSmithKline Five Moore Drive, Research Triangle Park NC 27709 USA

Publisher

Wiley

Subject

Organic Chemistry,Molecular Biology,Molecular Medicine,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cbic.202000298

Reference75 articles.

2. Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice